Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2019-01-18

Clinical Trial Update: Added Value of Contrast Enhanced Spectral Mammography, CESM. A Pilot Study. [NA]

View source ↗

Summary

This document reports a completed pilot study evaluating the added value of Contrast Enhanced Spectral Mammography (CESM) for breast cancer. It does not involve…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Region Skane | Conditions: Breast Cancer | NA | Status: COMPLETED